ストックスクリーナーアプリを入手
0.50
1.59%
-0.0081
アフターアワーズ：
.51
0.01
+2.00%
前日終値:
$0.5081
開ける：
$0.505
24時間の取引高:
621.30K
Relative Volume:
0.37
時価総額：
$39.08M
収益：
-
当期純損益:
$-27.26M
株価収益率:
-0.7246
EPS:
-0.69
ネットキャッシュフロー:
$-27.81M
1週間 パフォーマンス:
-11.19%
1か月 パフォーマンス:
-39.76%
6か月 パフォーマンス:
-67.32%
1年 パフォーマンス:
-69.51%
1日の値動き範囲:
$0.50
$0.5449
1週間の範囲:
$0.50
$0.565
52週間の値動き範囲:
$0.37
$2.57
Eyenovia Inc Stock (EYEN) Company Profile
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-01 | 開始されました | Northland Capital | Outperform |
| 2020-02-03 | ダウングレード | Oppenheimer | Outperform → Perform |
Eyenovia Inc (EYEN) 最新ニュース
Eyenovia Inc (EYEN) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Eyenovia Inc [EYEN] Investment Guide: What You Need to Know - Knox Daily
Financial Health Report: Eyenovia Inc (EYEN)’s Ratios Tell a Tale - The Dwinnex
There is no way Eyenovia Inc (EYEN) can keep these numbers up - SETE News
Eyenovia Inc (EYEN) requires closer examination - US Post News
Eyenovia Inc [EYEN] Chief Executive Officer makes an insider purchase of 27,071 shares worth 14077.0. - Knox Daily
A significant driver of top-line growth: Eyenovia Inc (EYEN) - SETE News
Analyzing Eyenovia Inc (EYEN) After Recent Trading Activity - Knox Daily
EYEN Shares Are Trading Higher Today: What You Need To Know - Benzinga
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization - The Malaysian Reserve
Eyenovia Inc (EYEN) did well last session? - US Post News
Investor’s Delight: Eyenovia Inc (EYEN) Closes Weak at 0.49, Down -3.67 - The Dwinnex
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization - The Manila Times
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization - Quantisnow
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercializati - ACROFAN USA
Eyenovia Announces Taiwan Export License Approval to Begin Shipment to the U.S. of Clobetasol Propionate Ophthalmic Suspension - Vision Monday
Eyenovia Inc [EYEN] Chief Executive Officer makes an insider acquire of 27,071 shares worth 14,077. - Knox Daily
Eyenovia Inc (EYEN) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
It makes sense and dollars to buy Eyenovia Inc (EYEN) stock - SETE News
Eyenovia Announces Taiwan Export License Approval to - GlobeNewswire
Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S. - StockTitan
Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S. - Yahoo Finance
Was Eyenovia Inc (EYEN)’s session last reading good? - US Post News
What Did We Find About Insider Trading At Eyenovia Inc (NASDAQ: EYEN)? - Stocks Register
Eyenovia appoints Andrew Jones as new CFO - Investing.com India
Eyenovia appoints Andrew Jones as new CFO - Investing.com
Eyenovia appoints Andrew Jones as new CFO By Investing.com - Investing.com Australia
Eyenovia appoints Andrew Jones as new CFO By Investing.com - Investing.com Canada
Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer - ForexTV.com
Eyenovia Appoints Andrew Jones as Chief Financial Officer - citybiz
Eyenovia Announces CFO Transition and New Financial Leadership - TipRanks
Eyenovia appoints Andrew Jones as new CFO By Investing.com - Investing.com UK
Eyenovia Announces Appointment of Experienced Finance and - GlobeNewswire
Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer - StockTitan
Eyenovia Inc’s latest rating changes from various analysts - Knox Daily
Michael M. Rowe Buys 27,071 Shares of Eyenovia, Inc. (NASDAQ:EYEN) Stock - Defense World
Insider Buying: Rowe Michael M, Eyenovia Inc [EYEN] Chief Executive Officer invested 27,071 shares - Knox Daily
Eyenovia CEO Michael Rowe buys $14k of company stock - Investing.com
Eyenovia CEO Michael Rowe buys $14k of company stock By Investing.com - Investing.com UK
Stocks of Eyenovia Inc (EYEN) are poised to climb above their peers - SETE News
Ratio Analysis: Unpacking Eyenovia Inc (EYEN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Eyenovia Inc’s Shares Reel: -25.43% Quarterly Revenue Decline Amid 40.79M Market Cap - The InvestChronicle
Eyenovia Inc (EYEN) gets rating Initiated from Northland Capital - Knox Daily
EYEN’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery - Quantisnow
Formosa Pharmaceuticals Announces Development Collaboration Agreement with Eyenovia - Quantisnow
Eyenovia Announces Closing of Public Offering - ForexTV.com
Eyenovia Announces Closing of Public Offering - citybiz
Eyenovia Announces Closing of Public Offering - GlobeNewswire
Eyenovia Unveils Updated Corporate Presentation for Stakeholders - TipRanks
A company insider recently bought 1,515,151 shares of Eyenovia Inc [EYEN]. Should You Buy? - Knox Daily
Eyenovia Inc (EYEN) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
1.31%
大文字化:
|
ボリューム (24 時間):